GLP-1 based therapeutics: simultaneously combating T2DM and obesityKristy M. Heppner, Diego Pérez–Tilve|Frontiers in Neuroscience|2015Cited by 116
GLP-1-mediated delivery of tesaglitazar improves obesity and glucose metabolism in male miceCarmelo Quarta, Timo D. Müller, Eric Baugé et al.|Nature Metabolism|2022Cited by 38
Chemogenetic engagement of different GPCR signaling pathways segregates the orexigenic activity from the control of whole-body glucose metabolism by AGRP neuronsValerie Espinal Abreu, Diego Pérez–Tilve|Molecular Metabolism|2024Cited by 3
GLP-1-mediated delivery of the PPAR𝛼/𝛾 dual-agonist Tesaglitazar improves obesity and glucose metabolism in miceCarmelo Quarta, Timo D. Müller, Kerstin Stemmer et al.|Research Square|2021Cited by 0